Literature DB >> 26446392

ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.

P Mulatero1, F Schiavi2, T A Williams1, S Monticone1, G Barbon2, G Opocher2, F Fallo3.   

Abstract

Idiopathic hyperaldosteronism (IHA) due to bilateral adrenal hyperplasia is the most common subtype of primary aldosteronism (PA). The pathogenesis of IHA is still unknown, but the bilateral disease suggests a potential predisposing genetic alteration. Heterozygous germline mutations of armadillo repeat containing 5 (ARMC5) have been shown to be associated with hypercortisolism due to sporadic primary bilateral macronodular adrenal hyperplasia and are also observed in African-American PA patients. We investigated the presence of germline ARMC5 mutations in a group of PA patients who had bilateral computed tomography-detectable adrenal alterations. We sequenced the entire coding region of ARMC5 and all intron/exon boundaries in 39 patients (37 Caucasians and 2 black Africans) with confirmed PA (8 unilateral, 27 bilateral and 4 undetermined subtype) and bilateral adrenal lesions. We identified 11 common variants, 5 rare variants with a minor allele frequency <1% and 2 new variants not previously reported in public databases. We did not detect by in silico analysis any ARMC5 sequence variations that were predicted to alter protein function. In conclusion, ARMC5 mutations are not present in a fairly large series of Caucasian patients with PA associated to bilateral adrenal disease. Further studies are required to definitively clarify the role of ARMC5 in the pathogenesis of adrenal nodules and aldosterone excess in patients with PA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26446392     DOI: 10.1038/jhh.2015.98

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  31 in total

1.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Authors:  Silvia Monticone; Namita G Hattangady; Koshiro Nishimoto; Franco Mantero; Beatrice Rubin; Maria Verena Cicala; Raffaele Pezzani; Richard J Auchus; Hans K Ghayee; Hirotaka Shibata; Isao Kurihara; Tracy A Williams; Judith G Giri; Roni J Bollag; Michael A Edwards; Carlos M Isales; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

2.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

3.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

4.  Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).

Authors:  Paolo Mulatero; Davide Tizzani; Andrea Viola; Chiara Bertello; Silvia Monticone; Giulio Mengozzi; Domenica Schiavone; Tracy Ann Williams; Silvia Einaudi; Antonio La Grotta; Franco Rabbia; Franco Veglio
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

5.  CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism.

Authors:  P Mulatero; D Schiavone; F Fallo; F Rabbia; C Pilon; L Chiandussi; L Pascoe; F Veglio
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Authors:  Guillaume Assié; Rossella Libé; Stéphanie Espiard; Marthe Rizk-Rabin; Anne Guimier; Windy Luscap; Olivia Barreau; Lucile Lefèvre; Mathilde Sibony; Laurence Guignat; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Franck Letourneur; Bilal Trabulsi; Alix Poussier; Nathalie Chabbert-Buffet; Françoise Borson-Chazot; Lionel Groussin; Xavier Bertagna; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

Review 8.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

9.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

10.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

View more
  19 in total

1.  Evolution of computed tomography-detectable adrenal nodules in patients with bilateral primary aldosteronism.

Authors:  Paolo Mulatero; Jacopo Burrello; Barbara Lucatello; Gilberta Giacchetti; Marialberta Battocchio; Francesco Fallo
Journal:  Endocrine       Date:  2015-12-08       Impact factor: 3.633

Review 2.  Hyperaldosteronism: How to Discriminate Among Different Disease Forms?

Authors:  Valentina Crudo; Silvia Monticone; Jacopo Burrello; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-02

3.  Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?

Authors:  Holly Emms; Ioanna Tsirou; Treena Cranston; Stylianos Tsagarakis; Ashley B Grossman
Journal:  Endocrine       Date:  2016-06-15       Impact factor: 3.633

4.  ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II).

Authors:  S M C De Sousa; M Stowasser; J Feng; A W Schreiber; P Wang; C N Hahn; R D Gordon; D J Torpy; H S Scott; L Gagliardi
Journal:  J Hum Hypertens       Date:  2017-10-12       Impact factor: 3.012

5.  Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Fady Hannah-Shmouni; Annabel Berthon; Fabio R Faucz; Juan Medina Briceno; Andrea Gutierrez Maria; Andrew Demidowich; Mirko Peitzsch; Jimmy Masjkur; Fidéline Bonnet-Serrano; Anna Vaczlavik; Jérôme Bertherat; Martin Reincke; Graeme Eisenhofer; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-07       Impact factor: 5.678

Review 6.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

Review 7.  Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.

Authors:  Georgia Pitsava; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Curr Cardiol Rep       Date:  2022-07-16       Impact factor: 3.955

Review 8.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

9.  Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.

Authors:  Constantine A Stratakis; Annabel Berthon
Journal:  Curr Opin Endocr Metab Res       Date:  2019-08-09

10.  A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.

Authors:  N M Albiger; D Regazzo; B Rubin; A M Ferrara; S Rizzati; E Taschin; F Ceccato; G Arnaldi; F Pecori Giraldi; A Stigliano; L Cerquetti; F Grimaldi; E De Menis; M Boscaro; M Iacobone; G Occhi; C Scaroni
Journal:  Endocrine       Date:  2016-04-19       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.